We extend our sincere thanks to everyone who visited our booth #900. With over 200 visits, more than 20 meetings, and hundreds of valuable new contacts, we are thrilled to have connected with so many industry professionals.
The event united all the participating companies and partners, who presented the 2023 achievements and the challenges they faced to the project manager. Each presentation showcased the remarkable progress and collaboration, underscoring our shared dedication to innovation and problem-solving.
The team presented the results of their study, in which they used CacoGoblet, a 21-day differentiated co-culture of human colon carcinoma cell lines (Caco-2 and HT-29), to screen the gastrointestinal anti-inflammatory properties of compounds.
This software was specially designed to manage our customers’ orders, as well as to automate the management of documentation and quality controls, facilitating orders worldwide and speeding up the generation of the necessary documents for customs.
In a recent publication in the Journal of Medicinal Chemistry, a collaborative research led by the scientist Dr. H. Day, in conjunction with a consortium of researchers, explored the development of allosteric inhibitors targeting SH2 domain-containing protein tyrosine phosphatase-2 (SHP2) for cancer therapy.
